Medexus Pharmaceuticals (MDP) AGM 2025 summary

Opening remarks and agenda

• Meeting opened with a welcome, procedural notes, and confirmation of recording consent.

• Agenda included presentation of financial statements, election of directors, and reappointment of auditors.

• Voting procedures and online participation guidelines were explained.

Financial performance review

• Consolidated financial statements for years ended March 31, 2025 and 2024, and the auditor's report were presented and made available to shareholders.

• No questions or comments were submitted regarding the financial statements.

Board and executive committee updates

• Seven directors were nominated for election, as specified in the management information circular.

• No additional nominations were received, and nominations were declared closed.